Form 8-K - Current report:
SEC Accession No. 0001104659-24-097364
Filing Date
2024-09-05
Accepted
2024-09-05 16:05:11
Documents
14
Period of Report
2024-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2423440d1_8k.htm   iXBRL 8-K 27853
  Complete submission text file 0001104659-24-097364.txt   250922

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vacc-20240901.xsd EX-101.SCH 3545
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vacc-20240901_def.xml EX-101.DEF 26916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vacc-20240901_lab.xml EX-101.LAB 36969
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vacc-20240901_pre.xml EX-101.PRE 25540
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2423440d1_8k_htm.xml XML 5491
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 241281400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)